AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

BIO-key International, Inc.

$2.65 -$3.25 (-55.08%)
NASDAQ · 14 Sep 2026 20:00 UTC
Previous Close
$2.65
Day Range
$2.62$2.79
Year Range
$2.57$19.7
Market Cap
2.88M
AVG Volume
63.91K
Trailing/Forward PE
-0.65/12.05
PEG ratio
0.01
Dividend Yield
-
Next Earnings Date
2026-11-13
Primary Exchange
NASDAQUS
Revenue (USD)
01M2M3M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BKYI Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q21.92M
26 Q12.15M
25 Q41.24M
25 Q31.55M
25 Q21.7M
25 Q11.61M
24 Q41.46M
24 Q32.14M
24 Q21.14M
24 Q12.18M
Net Income (USD)
-2M-1.5M-1M-500K024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BKYI Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q2-576.85K
26 Q1-165.04K
25 Q4-1.72M
25 Q3-964.85K
25 Q2-1.17M
25 Q1-736.54K
24 Q4-1.57M
24 Q3-738.96K
24 Q2-1.67M
24 Q1-510.29K
Operating Income (USD)
-2M-1.5M-1M-500K024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BKYI Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q2-529.4K
26 Q1-117.71K
25 Q4-1.64M
25 Q3-892.19K
25 Q2-1.08M
25 Q1-640.64K
24 Q4-1.27M
24 Q3-580.4K
24 Q2-1.65M
24 Q1-508.93K
EBITDA (USD)
-2M-1.5M-1M-500K024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BKYI EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q2-508.57K
26 Q1-137.87K
25 Q4-1.48M
25 Q3-874.08K
25 Q2-1.04M
25 Q1-602.61K
24 Q4-1.17M
24 Q3-415.98K
24 Q2-1.55M
24 Q1-407.12K
Cash Flows (USD)
-2M-1M01M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BKYI Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q2-845.75K
26 Q1-358K
25 Q4-1.83M
25 Q3-1.12M
25 Q2-881.49K
25 Q1-839.88K
24 Q4-504.56K
24 Q3-1.3M
24 Q2-1.42M
24 Q1295.21K
EPS (USD)
-15-10-5024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BKYI EPS (USD) by quarter
PeriodEPS (USD)
26 Q2-0.56
26 Q1-0.2
25 Q4-1.85
25 Q3-1.46
25 Q2-2.01
25 Q1-1.57
24 Q4-5.17
24 Q3-3.91
24 Q2-10.02
24 Q1-3.16
Expenses (USD)
-1M01M2M3MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BKYI Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q22.2M
26 Q11.89M
25 Q42.62M
25 Q32.09M
25 Q22.32M
25 Q11.97M
24 Q42.46M
24 Q32.28M
24 Q22.53M
24 Q12.39M
Cash & Debt (USD)
01M2M3M4MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BKYI Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q21.38M
26 Q12.25M
25 Q42.69M
25 Q32.04M
25 Q22.28M
25 Q13.13M
24 Q4437.6K
24 Q31.8M
24 Q21.26M
24 Q1690.45K
Debt ratios
-0.500.5124 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BKYI Debt ratios by quarter
PeriodDebt ratios
26 Q20.41
26 Q10.62
25 Q40.5
25 Q30.16
25 Q20.51
25 Q10.58
24 Q4-0.38
24 Q3-0.08
24 Q2-0.1
24 Q10.04
Margins
0%25%50%75%100%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BKYI Margins by quarter
PeriodMargins
26 Q287.19%
26 Q182.46%
25 Q478.14%
25 Q376.9%
25 Q272.65%
25 Q182.61%
24 Q482.06%
24 Q378.31%
24 Q277.02%
24 Q186.26%
Return on Capital
-600%-400%-200%0%200%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BKYI Return on Capital by quarter
PeriodReturn on Capital
26 Q2-13.31%
26 Q1-2.22%
25 Q4-22.45%
25 Q3-15.96%
25 Q2-17.04%
25 Q1-9.79%
24 Q4-41.55%
24 Q3-555.43%
24 Q2157.81%
24 Q1-95.25%
Shares Outstanding
0500K1M1.5M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BKYI Shares Outstanding by quarter
PeriodShares Outstanding
26 Q21.04M
26 Q11.04M
25 Q4929.36K
25 Q3658.75K
25 Q2582.11K
25 Q1470.24K
24 Q4303.22K
24 Q3188.97K
24 Q2166.3K
24 Q1161.53K
Dividends (USD)
0100200300400Jul 97
BKYI Dividends (USD) by quarter
PeriodDividends (USD)
Jul 97384
Employee Count
02040602016201720182019202020212022202320242025
BKYI Employee Count by quarter
PeriodEmployee Count
202542
202442
202342
202252
202151
202034
201915
201815
201719
201621
Book Value Per Share (USD)
-100102024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BKYI Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q24.18
26 Q17.18
25 Q48.25
25 Q39.18
25 Q211.77
25 Q116.01
24 Q412.44
24 Q30.7
24 Q2-6.35
24 Q13.32
Total Assets (USD)
05M10M15M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
BKYI Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q27.48M
26 Q110.68M
25 Q410.87M
25 Q310.11M
25 Q210.52M
25 Q111.18M
24 Q48.62M
24 Q36.4M
24 Q24.8M
24 Q14.17M
Free Cash Flow Yield
-300%-200%-100%0%med -103.89%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
BKYI Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-151.26%
Sep 26-142.65%
Aug 26-130.14%
Aug 26-130.57%
Aug 26-126.05%
Aug 26-100.51%
Jul 26-92.27%
Jul 26-89.03%
Jul 26-88.06%
Jul 26-81.34%
Jul 26-98.8%
Jun 26-88.06%
Jun 26-132.38%
Jun 26-121.5%
Jun 26-123.13%
May 26-112.43%
May 26-107.06%
May 26-119.66%
May 26-97.42%
May 26-95.41%
Apr 26-83.5%
Apr 26-80.72%
Apr 26-89.85%
Apr 26-93.65%
Mar 26-88.75%
Mar 26-80.72%
Mar 26-78.48%
Mar 26-77.4%
Feb 26-77.76%
Feb 26-88.6%
Feb 26-86.93%
Feb 26-76.7%
Jan 26-70.05%
Jan 26-88.14%
Jan 26-85.76%
Jan 26-88.75%
Jan 26-86.19%
Dec 25-83.92%
Dec 25-79.21%
Dec 25-73.17%
Dec 25-66.48%
Nov 25-62.94%
Nov 25-57.66%
Nov 25-53.7%
Nov 25-62.91%
Oct 25-77.59%
Oct 25-78.6%
Oct 25-82.91%
Oct 25-85.24%
Oct 25-76.42%
Sep 25-80.27%
Sep 25-78.09%
Sep 25-78.5%
Sep 25-80.48%
Aug 25-80.7%
Aug 25-78.6%
Aug 25-82.57%
Aug 25-114.72%
Aug 25-113.82%
Jul 25-103.7%
Jul 25-104.46%
Jul 25-107.98%
Jul 25-107.05%
Jun 25-104.08%
Jun 25-106.52%
Jun 25-110.89%
Jun 25-101.04%
May 25-102.84%
May 25-109.49%
May 25-103.7%
May 25-122.19%
May 25-116.59%
Apr 25-121.58%
Apr 25-292.72%
Apr 25-287.89%
Apr 25-287.1%
Mar 25-257.12%
Mar 25-197.45%
Mar 25-174.41%
Mar 25-197.45%
Feb 25-207.23%
Feb 25-203.2%
Feb 25-172.97%
Feb 25-168.79%
Jan 25-156.19%
Jan 25-133.31%
Jan 25-120.98%
Jan 25-139.53%
Jan 25-125.33%
Dec 24-148.44%
Dec 24-240.57%
Dec 24-216.66%
Dec 24-188.56%
Nov 24-232.55%
Nov 24-237.84%
Nov 24-222.66%
Nov 24-146.42%
Nov 24-136.98%
Oct 24-244.39%
Oct 24-245.09%
Price to Sales
00.20.40.60.81med 0.6Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
BKYI Price to Sales by quarter
PeriodPrice to Sales
Sep 260.4
Sep 260.43
Aug 260.47
Aug 260.46
Aug 260.48
Aug 260.63
Jul 260.69
Jul 260.71
Jul 260.72
Jul 260.78
Jul 260.64
Jun 260.72
Jun 260.58
Jun 260.63
Jun 260.43
May 260.47
May 260.5
May 260.44
May 260.54
May 260.56
Apr 260.64
Apr 260.66
Apr 260.59
Apr 260.57
Mar 260.6
Mar 260.66
Mar 260.68
Mar 260.69
Feb 260.68
Feb 260.6
Feb 260.61
Feb 260.69
Jan 260.76
Jan 260.6
Jan 260.62
Jan 260.6
Jan 260.62
Dec 250.63
Dec 250.67
Dec 250.72
Dec 250.8
Nov 250.84
Nov 250.92
Nov 250.99
Nov 250.81
Oct 250.66
Oct 250.65
Oct 250.61
Oct 250.6
Oct 250.67
Sep 250.64
Sep 250.65
Sep 250.65
Sep 250.63
Aug 250.63
Aug 250.65
Aug 250.62
Aug 250.56
Aug 250.56
Jul 250.62
Jul 250.61
Jul 250.59
Jul 250.6
Jun 250.61
Jun 250.6
Jun 250.58
Jun 250.63
May 250.62
May 250.58
May 250.62
May 250.35
May 250.36
Apr 250.35
Apr 250.21
Apr 250.21
Apr 250.22
Mar 250.24
Mar 250.31
Mar 250.35
Mar 250.31
Feb 250.3
Feb 250.3
Feb 250.36
Feb 250.37
Jan 250.4
Jan 250.46
Jan 250.51
Jan 250.44
Jan 250.49
Dec 240.42
Dec 240.26
Dec 240.29
Dec 240.33
Nov 240.27
Nov 240.26
Nov 240.28
Nov 240.32
Nov 240.34
Oct 240.19
Oct 240.19
Price to Book
0102030med 0.66Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
BKYI Price to Book by quarter
PeriodPrice to Book
Sep 260.63
Sep 260.67
Aug 260.74
Aug 260.73
Aug 260.76
Aug 260.56
Jul 260.61
Jul 260.63
Jul 260.64
Jul 260.69
Jul 260.57
Jun 260.64
Jun 260.46
Jun 260.5
Jun 260.45
May 260.49
May 260.52
May 260.46
May 260.57
May 260.58
Apr 260.66
Apr 260.69
Apr 260.62
Apr 260.59
Mar 260.62
Mar 260.69
Mar 260.71
Mar 260.72
Feb 260.71
Feb 260.63
Feb 260.64
Feb 260.72
Jan 260.79
Jan 260.63
Jan 260.65
Jan 260.62
Jan 260.64
Dec 250.66
Dec 250.7
Dec 250.76
Dec 250.83
Nov 250.88
Nov 250.96
Nov 251.03
Nov 250.82
Oct 250.66
Oct 250.65
Oct 250.62
Oct 250.6
Oct 250.67
Sep 250.64
Sep 250.66
Sep 250.65
Sep 250.64
Aug 250.64
Aug 250.65
Aug 250.62
Aug 250.47
Aug 250.47
Jul 250.52
Jul 250.52
Jul 250.5
Jul 250.5
Jun 250.52
Jun 250.51
Jun 250.49
Jun 250.53
May 250.52
May 250.49
May 250.52
May 250.64
May 250.67
Apr 250.64
Apr 2510.16
Apr 2510.33
Apr 2510.35
Mar 2511.56
Mar 2515.06
Mar 2517.04
Mar 2515.06
Feb 2514.35
Feb 2514.63
Feb 2517.19
Feb 2517.61
Jan 2519.03
Jan 2522.3
Jan 2524.57
Jan 2521.31
Jan 2523.72
Dec 2420.03
Dec 2412.36
Dec 2413.72
Dec 2415.77
Nov 2412.78
Nov 2412.5
Nov 2413.35
Aug 244.25
Aug 244.19
Jul 244.88
Jul 244.85
BIO-key International, Inc.
BKYI
Stockpicker

Video analysis: BKYI

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: BKYI

Biometric Identity Security Provider BIO-key Participates at H.C. Wainwright Global Investment Conference Sept.

globenewswire.com · 1 Sep 2026

Biometric Identity Security Provider BIO-key Participates at H.C. Wainwright Global Investment Conference Sept.

HOLMDEL, N.J., Sept. 01, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), a global leader in Identity and Access Management and biometric authentication technologies, announced that its CEO Michael DePasquale will be available for virtual meetings at H.C.

BIO-key International, Inc. (BKYI) Q2 2026 Earnings Call Transcript

seekingalpha.com · 14 Aug 2026

BIO-key International, Inc. (BKYI) Q2 2026 Earnings Call Transcript

BIO-key International, Inc. (BKYI) Q2 2026 Earnings Call Transcript

BIO-key's Bottom Line Improves 51% on 13% Rise in Q2 Revenues Reflecting Strength with Government, Defense, and Financial Sector Customers Globally; Call Tomorrow at 10am ET

globenewswire.com · 13 Aug 2026

BIO-key's Bottom Line Improves 51% on 13% Rise in Q2 Revenues Reflecting Strength with Government, Defense, and Financial Sector Customers Globally; Call Tomorrow at 10am ET

BIO-key's (BKYI)Bottom Line Improves 51% on 13% Rise in Q2 Revenues Reflecting Strength with Government, Defense, and Financial Sector Customers Globally.

BIO-key International Enters into $2.5 Million Warrant Inducement Transaction

globenewswire.com · 11 Aug 2026

BIO-key International Enters into $2.5 Million Warrant Inducement Transaction

HOLMDEL, N.J., Aug. 11, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), a global innovator in Identity and Access Management (IAM) and biometric authentication solutions, today announced it has entered into a warrant inducement agreement with an existing institutional investor for the exercise of certain outstanding warrants that the Company issued on October 28, 2025 (the “Warrants”).

Portuguese National Security Agency Selects BIO-key and Visualforma to Strengthen Identity Security

globenewswire.com · 10 Aug 2026

Portuguese National Security Agency Selects BIO-key and Visualforma to Strengthen Identity Security

Portuguese national security agency selects BIO-key (BKYI) and Visualforma to strengthen identity security with advanced IAM and biometric authentication.

Advanced Authentication Solutions Provider BIO-key Hosts Q2 Investor Call Friday, August 14th at 10am ET

globenewswire.com · 7 Aug 2026

Advanced Authentication Solutions Provider BIO-key Hosts Q2 Investor Call Friday, August 14th at 10am ET

HOLMDEL, N.J., Aug. 07, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), a global leader in Identity and Access Management and biometric authentication technologies, will host its Q2'26 investor call and webcast on Friday, August 14th at 10 a.m.

BIO-key and Maktabi Tech Partner to Advance Identity Security Across Saudi Arabia's Education Sector

globenewswire.com · 6 Aug 2026

BIO-key and Maktabi Tech Partner to Advance Identity Security Across Saudi Arabia's Education Sector

BIO-key's proven IAM platform and Maktabi Tech's education market leadership bring global best practices and regional expertise to schools in Saudi Arabia

BIO-key International (NASDAQ:BKYI) Share Price Crosses Above 50-Day Moving Average   – Should You Sell?

defenseworld.net · 4 Aug 2026

BIO-key International (NASDAQ:BKYI) Share Price Crosses Above 50-Day Moving Average – Should You Sell?

BIO-key International Inc. (NASDAQ: BKYI - Get Free Report) passed above its fifty day moving average during trading on Monday. The stock has a fifty day moving average of $4.44 and traded as high as $4.60. BIO-key International shares last traded at $3.76, with a volume of 72,730 shares changing hands. Wall Street Analyst Weigh

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.